Isavuconazonium
ATC — · 3 markets · 8 records
Isavuconazonium
Forms
US 3 records · 3 strengths
TW 3 records · 3 strengths
- 100 mgcapsuleCRESEMBA驅黴霸100毫克膠囊
- 40 mgcapsuleCRESEMBA驅黴霸40毫克膠囊
- 200 mginjectionCRESEMBA 200 mg powder for concentrate for solution for infusion驅黴霸200毫克注射劑
AU 2 records · 1 strengths
Records without a stated strength · 1 CRESEMBA、ISAVUCONAZOLE ADVZ
| Strength / form / release | US | AU | TW |
|---|---|---|---|
| 100 mg capsule | CRESEMBA | CRESEMBA 驅黴霸100毫克膠囊 | |
| 40 mg capsule | CRESEMBA | CRESEMBA 驅黴霸40毫克膠囊 | |
| 200 mg injection | CRESEMBA 200 mg powder for concentrate for solution for infusion 驅黴霸200毫克注射劑 | ||
| 40 mg injection | CRESEMBA | ||
unknown | CRESEMBA ISAVUCONAZOLE ADVZ |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.